P10415

PTMD Annotation Information


※ Protein Information

Tag Content
UniProt Accession BCL2_HUMAN; P10415;
Entrez ID 596
GenBank Protein ID NM_000633.2; NM_000657.2;
GenBank Nucleotide ID NP_000624.2; NP_000648.2;
Protein Name Apoptosis regulator Bcl-2
Gene Name BCL2
Organism Homo sapiens
NCBI Taxa ID 9606
Functional DescriptionSuppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (PubMed:17418785).
Sequence
(Fasta)
MAHAGRTGYD NREIVMKYIH YKLSQRGYEW DAGDVGAAPP GAAPAPGIFS SQPGHTPHPA 60
ASRDPVARTS PLQTPAAPGA AAGPALSPVP PVVHLTLRQA GDDFSRRYRR DFAEMSSQLH 120
LTPFTARGRF ATVVEELFRD GVNWGRIVAF FEFGGVMCVE SVNREMSPLV DNIALWMTEY 180
LNRHLHTWIQ DNGGWDAFVE LYGPSMRPLF DFSWLSLKTL LSLALVGACI TLGAYLGHK 240

※ PTM-Disease Association

NumPTMDiseaseCell TypeTypePTM SitePMID
1PhosphorylationLung cancer/carcinomaA549 cell lineP22466960
[Reference]: Activation of ERK-p53 and ERK-mediated phosphorylation of Bcl-2 are involved in autophagic cell death induced by the c-Met inhibitor SU11274 in human lung cancer A549 cells
2PhosphorylationAcute lymphoblastic leukaemiaU14737078
[Reference]: Overexpression of protein kinase C alpha (PKC alpha) promotes Bcl2 phosphorylation and chemoresistance in human acute leukemia cells.
3Serine PhosphorylationLung cancer/carcinomacell linePS7023514933
[Reference]: Blocking IL17A reduces the expression of BCL2 and promotes the interaction of BCL2 and GSK3B in BLM-induced fibrotic lung tissue
4Serine PhosphorylationColon cancer/carcinomaUS8725826088
[Reference]: High pBcl-2-S87 had poor outcomes

※ Disease Cross-ref Annotation

DatabaseAnnotation
Cancer Gene Census
NHL, CLL
CTD (Curated)
(count: 50)
(view all)
MESH:D000230 ; Adenocarcinoma
MESH:D018262 ; Adenocarcinoma, Clear Cell
MESH:D000236 ; Adenoma
MESH:C554498 ; AIDS-related Kaposi sarcoma
MESH:D000544 ; Alzheimer Disease
MESH:D001249 ; Asthma
HGMD
(count: 2)
CM980213; Autoimmune disease, resistance to, association; Missense/nonsense
CR070417; Prostate cancer, reduced risk, association with; Regulatory
GWASdb
(count: 28)
(view all)
rs4987867; HDL cholesterol; cholesterol ester storage disease|cholesterol embolism|coronary artery disease
rs4987867; Triglycerides; coronary artery disease|lipid metabolism disorder|arteriosclerosis
rs4987856; Chronic lymphocytic leukemia; chronic lymphocytic leukemia
rs4987855; Chronic lymphocytic leukemia; chronic lymphocytic leukemia
rs4987852; Chronic lymphocytic leukemia; chronic lymphocytic leukemia
rs17756073; Multiple complex diseases; Null

※ PTM Sites

PTM Modification Sites
Phosphorylation
(count: 8)
(view all)
235       ACITLGAYLGHK***     dbPAF
24        KYIHYKLSQRGYEWD     dbPAF
56        FSSQPGHTPHPAASR     dbPAF
69        SRDPVARTSPLQTPA     dbPAF
70        RDPVARTSPLQTPAA     dbPAF
74        ARTSPLQTPAAPGAA     dbPAF

※ Protein-Protein Interaction

NetworkInteraction
ABSource
F5GXF0P10415HPRD; IntAct
F8W034P10415HPRD
H0YG33P10415HPRD
H3BMF4P10415HPRD; IntAct
O15151P10415MINT
O15304P10415IntAct
O43521P10415HPRD; IntAct; MINT;IntAct
O54918P10415MINT
O60238P10415HPRD; IntAct
O60551P10415HPRD; MINT
O95429P10415HPRD
O95817P10415HPRD
P00441P10415HPRD
P01106P10415HPRD
P01111P10415HPRD
P01112P10415HPRD
P01116P10415HPRD
P04049P10415HPRD; DIP
P04637P10415HPRD; DIP; IntAct; MINT
P09874P10415HPRD
P10301P10415HPRD
P10415P10415HPRD; DIP; IntAct
P10415P16615HPRD
P10415P17252HPRD
P10415P17612HPRD
P10415P21796DIP
P10415P24941HPRD
P10415P27361HPRD
P10415P28482HPRD; MINT
P10415P29590HPRD
P10415P36873IntAct
P10415P42574HPRD
P10415P45983HPRD; MINT
P10415P49023HPRD
P10415P49768HPRD
P10415P50416HPRD
P10415P51451HPRD
P10415P51572HPRD; IntAct
P10415P55957HPRD; DIP; IntAct
P10415P62136IntAct;HPRD
P10415P62140IntAct
P10415P63098MINT
P10415P67775HPRD; MINT
P10415P99999HPRD
P10415Q07812DIP; IntAct; MINT;HPRD
P10415Q07817HPRD;IntAct
P10415Q07820DIP
P10415Q08209HPRD
P10415Q12981HPRD
P10415Q12982HPRD; IntAct
P10415Q12983HPRD; IntAct
P10415Q13323HPRD; DIP; IntAct
P10415Q13526HPRD
P10415Q13625DIP; MINT;HPRD
P10415Q13794HPRD; IntAct
P10415Q14318MINT;HPRD
P10415Q14457HPRD; DIP; IntAct; MINT
P10415Q14643HPRD; DIP
P10415Q14790HPRD; IntAct
P10415Q15172HPRD
P10415Q15388HPRD
P10415Q15637HPRD
P10415Q15759HPRD
P10415Q16539HPRD
P10415Q16611HPRD; IntAct
P10415Q16637HPRD
P10415Q7Z465HPRD
P10415Q86Y07IntAct
P10415Q8IVG9MINT
P10415Q92934HPRD; IntAct
P10415Q96BY2HPRD
P10415Q96HR8MINT
P10415Q96LC9HPRD
P10415Q96PG8HPRD
P10415Q99638HPRD
P10415Q99640HPRD
P10415Q99933HPRD; DIP
P10415Q9BXH1IntAct
P10415Q9BZR8HPRD
P10415Q9C000HPRD; DIP; IntAct
P10415Q9C0C7MINT
P10415Q9HCN2HPRD
P10415Q9HD36HPRD
P10415Q9NQC3HPRD
P10415Q9NYF8HPRD
P10415Q9NZS9HPRD
P10415Q9Y287HPRD